ArticleVascular health and risk management2018

Antihypertensive effect of the mineralocorticoid receptor antagonist eplerenone: a pooled analysis of patient-level data from comparative trials using regulatory-approved doses.

Mireille Fernet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.